FDA Updates Draft Guidance on Promotional Labeling and Adver

On April 25, 2024, FDA published a revised draft guidance, Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and...

Related Keywords

, King Spalding , Promotional Labeling , Advertising Considerations , Prescription Biological Reference Products , Biosimilar Products , Interchangeable Biosimilar Products , Revised Draft Guidance , Client Alert , Biosimilar User Fee Amendments , Revised Draft , Draft Guidance , Procedures Fiscal Years , Prescription Biological Reference ,